Reference : Doit-on encore recommander le vaccin BCG?
Scientific journals : Article
Human health sciences : Immunology & infectious disease
http://hdl.handle.net/2268/73687
Doit-on encore recommander le vaccin BCG?
French
[en] should the Bcg Vaccine Still Be Recommended?
Collette, Georges mailto [Université de Liège - ULg > Département des sciences cliniques > Médecine générale >]
Bourhaba, Maryam [Université de Liège - ULg > > Département des sciences cliniques >]
Moutschen, Michel mailto [Université de Liège - ULg > Département des sciences cliniques > Immunopathologie - Transplantation]
2006
Revue Médicale de Liège
61
5-6, May-Jun
430-2
Yes (verified by ORBi)
National
0370-629X
[en] The BCG vaccine has demonstrated its efficacy to protect young children from severe extrapulmonary forms of tuberculosis. Nevertheless, the immunity induced by the vaccine disappears in adults and cannot be boosted by readministration of BCG. Adverse effects of BCG are rare, but potentially dangerous (i.e. disseminated vaccinal infections) and they justify the fact that BCG should not be administered anymore in Western European countries where the incidence of pediatric tuberculous meningitis is very low. The vaccine is still recommanded for children living in countries with high tuberculosis prevalence and for resident children leaving Belgium for these countries.
http://hdl.handle.net/2268/73687

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Open access
Doit-on encore recommander le vaccin bcg - 2006.pdfPublisher postprint431.3 kBView/Open

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.